Antibody-Drug Conjugates in the Treatment of Metastatic Breast Cancer: The Emerging Questions of Sequence and Resistance

Antibody-Drug Conjugates in the Treatment of Metastatic Breast Cancer: The Emerging Questions of Sequence and Resistance

Metastatic breast cancer continues to present significant therapeutic challenges, necessitating ongoing exploration of innovative treatments. The use of antibody-drug conjugates (ADCs) represents an effective treatment strategy that combines the targeting capabilities of monoclonal antibodies with t...

Full description

Saved in:
Bibliographic Details
Main Authors: Allan Relecom, Francesco Sciotto, Mathieu Chevallier, José Luis Sandoval
Format: Article
Language:English
Published: THE HEALTHBOOK COMPANY LTD. 2024-10-01
Series:healthbook TIMES. Oncology Hematology
Online Access:https://doi.org/10.36000/HBT.OH.2024.21.155
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items